# US 2010/0169259 A1 · Methods and systems for presenting an inhalation experience

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0169259 A1
- Document ID: US20100169259A1
- Status: Published application
- Kind: A1
- Application number: 12/387,151
- Filed: 2009-04-28
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: Searete LLC, a limited liability corporation of the State of Delaware
- Inventors: Roderick A. Hyde; Robert Langer; Eric C. Leuthardt; Robert W. Lord; Elizabeth A. Sweeney; Clarence T. Tegreene; Lowell L. Wood, JR.
- Web page: https://patentgrep.com/patent/US20100169259A1

## CPC

- A61B 5/4839: {combined with drug delivery}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/165: {Evaluating the state of mind, e.g. depression, anxiety}
- A61B 5/411: {Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance}
- A61B 5/4833: {Assessment of subject's compliance to treatment}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/6822: {Neck}
- A61M 11/00: Sprayers or atomisers specially adapted for therapeutic purposes (in general B05B; {aerosol containers B65D83/14})
- A61M 15/00: Inhalators {(drug delivery in endotracheal tubes A61M16/04)}
- A61M 15/02: with activated or ionised {fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices}; Ozone-inhalators {with radioactive tagged particles}
- A61M 15/08: Inhaling devices inserted into the nose
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 20/13: delivered from dispensers
- G16H 40/67: for remote operation
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/02: Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/11: Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb {(A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721)}
- A61B 5/145: Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value {; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue} (non-radiation detecting or locating of foreign bodies in blood A61B5/06)
- A61M 15/0028: {using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up}
- A61M 15/0065: {Inhalators with dosage or measuring devices (A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52)}
- A61M 15/009: {using medicine packages with incorporated spraying means, e.g. aerosol cans (pocket atomiser of the injector type A61M11/08)}
- A61M 2021/0016: {by the smell sense}
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/50: with microprocessors or computers
- A61M 2205/581: by audible feedback
- A61M 2205/582: by tactile feedback
- A61M 2205/583: by visual feedback
- A61M 2205/588: by olfactory feedback, i.e. smell
- A61M 2209/088: on the body
- A61M 2230/201: Glucose concentration
- A61M 2230/205: partial oxygen pressure (P-O2)
- A63F 2300/65: for computing the condition of a game character
- A63F 2300/6692: using special effects, generally involving post-processing, e.g. blooming
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A63F: CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR

## Abstract

Methods, computer program products, and systems are described that include accepting an indication of an individual's compliance with an artificial sensory experience and presenting an indication of an inhalation device-dispensed bioactive agent at least partially based on the indication of the individual's compliance with the artificial sensory experience.

## Claims

### Claim at position 1

1-70. (canceled)

### Claim 71

A system, comprising:
an accepter module; and
a presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience.

### Claim 72 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
a compliance accepter module.

### Claim 73 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
a self compliance accepter module.

### Claim 74 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
a health care provider report accepter module.

### Claim 75 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
an artificial sensory experience provider report accepter module.

### Claim 76 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
a usage accepter module.

### Claim 77 (depends on 76)

The system of claim 76, wherein the usage accepter module comprises:
a computer usage accepter module.

### Claim 78 (depends on 77)

The system of claim 77, wherein the computer usage accepter module comprises:
a virtual world usage accepter module.

### Claim 79 (depends on 76)

The system of claim 76, wherein the usage accepter module comprises:
an interactive device usage accepter module.

### Claim 80 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
a presence detector output accepter module.

### Claim 81 (depends on 80)

The system of claim 80, wherein the presence detector output accepter module comprises:
a detection system output accepter module.

### Claim 82 (depends on 71)

The system of claim 71, wherein the accepter module comprises:
a physiological measurement accepter module.

### Claim 83 (depends on 82)

The system of claim 82, wherein the physiological measurement accepter module comprises:
a body characteristic measurement accepter module.

### Claim 84 (depends on 82)

The system of claim 82, wherein the physiological measurement accepter module comprises:
a continuous monitorer module.

### Claim 85 (depends on 82)

The system of claim 82, wherein the physiological measurement accepter module comprises:
a parameter value accepter module.

### Claim 86 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a prescription presenter module.

### Claim 87 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a real time presenter module.

### Claim 88 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a side effect indicator module.

### Claim 89 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a recommendation algorithm utilizer module.

### Claim 90 (depends on 89)

The system of claim 89, wherein the recommendation algorithm utilizer module comprises:
a comparison algorithm utilizer module.

### Claim 91 (depends on 89)

The system of claim 89, wherein the recommendation algorithm utilizer module comprises:
a contraindication algorithm utilizer module.

### Claim 92 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a recommendation indicator module.

### Claim 93 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a matching algorithm utilizer module.

### Claim 94 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a compatibility determiner module.

### Claim 95 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
an output device presenter module.

### Claim 96 (depends on 95)

The system of claim 95, wherein the output device presenter module comprises:
a user interface presenter module.

### Claim 97 (depends on 95)

The system of claim 95, wherein the output device presenter module comprises:
a mobile device presenter module.

### Claim 98 (depends on 71)

The system of claim 71, wherein the presenter module configured to present an indication of an inhalation device-dispensed bioactive agent at least partially based on an indication of an individual's compliance with an artificial sensory experience comprises:
a third party presenter module.

### Claim 99 (depends on 98)

The system of claim 98, wherein the third party presenter module comprises:
a health care provider presenter module.

### Claim 100 (depends on 98)

The system of claim 98, wherein the third party presenter module comprises:
a selective presenter module.
